Company page

Dermata Therapeutics, Inc.

Dermata Therapeutics, Inc. (ticker: DRMA) is a publicly traded company in the American market with a market capitalization of approximately $5.3 million. The company focuses on developing innovative therapies for skin conditions. Dermata aims to address unmet needs in dermatology through its research and development efforts.